Live Breaking News & Updates on மார்க்கா டர்கோ

Press release content from PR Newswire. The AP news staff was not involved in its creation.
DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient
May 10, 2021 GMT
Sirtex DOORwaY-90 Study Logo
First prospective multicenter U.S.-based trial for indication expansion of SIR-Spheres® Y-90 resin microspheres taking place in 15 sites across the U.S.
WOBURN, Mass., May 10, 2021 /PRNewswire/ Sirtex Medical (“Sirtex”), a leading manufacturer of targeted liver cancer therapies, announced that the first patient has been enrolled in DOORwaY-90, a study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres in patients with unresectable hepatocellular carcinoma (HCC). ....

United States , Comunidad Autonoma De Cataluna , Cheenu Kappadath , Armeen Mahvash , Marka Turco , Douglas Murrey , Imaging Associates , Providence Sacred Heart Medical Center , Development For Sirtex , European Union Ce Mark , Sirtex Pty Ltd , Interventional Radiologist At Inland Imaging Associates , Objective Response , Inland Imaging Associates , Global Chief Medical Officer , Barcelona Clinic Liver Cancer , Interventional Radiologist , Spheres Pty , European Union , Premarket Approval , ஒன்றுபட்டது மாநிலங்களில் , காமுனிடட தன்னாட்சி டி கடலுள் , மார்க்கா டர்கோ , இமேஜிங் கூட்டாளிகள் , ப்ராவிடெந்ஸ் புனிதமானது இதயம் மருத்துவ மையம் , ஐரோப்பிய தொழிற்சங்கம் ஸ் குறி ,